These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2499248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.
    Golper TA, Hartstein AI, Morthland VH, Christensen JM.
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1787-90. PubMed ID: 3435126
    [Abstract] [Full Text] [Related]

  • 4. Altered disposition of fleroxacin in patients with cystic fibrosis.
    Mimeault J, Vallée F, Seelmann R, Sörgel F, Ruel M, LeBel M.
    Clin Pharmacol Ther; 1990 May; 47(5):618-28. PubMed ID: 2111750
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.
    Uehlinger DE, Schaedeli F, Kinzig M, Sörgel F, Frey FJ.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1903-9. PubMed ID: 8843301
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The metabolism and pharmacokinetics of fleroxacin in healthy subjects.
    Griggs DJ, Wise R, Kirkpatrick B, Ashby JP.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():191-4. PubMed ID: 3144537
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.
    Yeung SM, Walker SE, Tailor SA, Awdishu L, Tobe S, Yassa T.
    Perit Dial Int; 2004 Oct; 24(5):447-53. PubMed ID: 15490984
    [Abstract] [Full Text] [Related]

  • 9. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
    Taburet AM, Devillers A, Thomare P, Fillastre JP, Veyssier P, Singlas E.
    Clin Pharmacokinet; 1990 Jul; 19(1):80-8. PubMed ID: 2116257
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I, Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ.
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal handling of fleroxacin in rabbits, dogs, and humans.
    Shiba K, Saito A, Shimada J, Hori S, Kaji M, Miyahara T, Kusajima H, Kaneko S, Saito S, Ooie T.
    Antimicrob Agents Chemother; 1990 Jan; 34(1):58-64. PubMed ID: 2109576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E.
    Am J Med; 1993 Mar 22; 94(3A):70S-74S. PubMed ID: 8452185
    [Abstract] [Full Text] [Related]

  • 17. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D, Schurig R, Weihermüller K, Förster D.
    Antimicrob Agents Chemother; 1980 Jul 22; 18(1):81-7. PubMed ID: 6448024
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
    Panneton AC, Bergeron MG, LeBel M.
    Antimicrob Agents Chemother; 1988 Oct 22; 32(10):1515-20. PubMed ID: 3142338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.